Back to Authors

Roesler, Kimberly

A5082347293 | I114493937

Mayo Clinic

Creighton University

Citations 3

Long‐term experience with intraoperative electron radiation therapy boost in extremity sarcoma

Journal of Surgical Oncology | July 20, 2022 | Volume: 126 | Issue: 7 | Pages: 1279-1287

10.1002/jso.27024 | PMID 35856506

AbstractBackgroundIn patients with extremity soft tissue sarcoma (eSTS), we describe outcomes of preoperative external beam radiation therapy (EBRT), limb‐sparing surgery (LSS), and intraoperative electron radiation therapy (IOERT).MethodsOne hundred and eighteen patients with eSTS treated between October 17, 2002 and July 28, 2021 were identified. EBRT was delivered preoperatively followed by LSS and IOERT.ResultsThe median follow‐up was 24.9 months. The presentation was primary in 102 (94%) patients and recurrent in 6 (6%) patients. Tumor location was lower extremity in 82 (76%) patients and upper extremity in 26 (24%) patients. Stage distribution was as follows: 3 (3%) IA, 24 (22%) IB, 31 (29%) II, 24 (22%) IIIA, and 25 (23%) IIIB. Final surgical margins were negative in 96 (89%) patients. The 5‐year local control, failure‐free survival, and overall survival were 94%, 75%, and 64%, respectively. Univariate analysis identified age >50, lower extremity, and higher grade as significant negative prognostic factors for overall survival. Grade 3 fracture or osteoradionecrosis requiring surgical fixation, neuropathy, and lymphedema occurred in 7 (6%), 1 (1%), and 0 patients, respectively.ConclusionsThis study represents one of the largest series using preoperative EBRT, LSS, and IOERT for eSTS, with high local control and a low rate of late severe toxicity.
Deep Brain Stimulation and Cognitive Outcomes Among Patients With Parkinson’s Disease: A Historical Cohort Study

The Journal of Neuropsychiatry and Clinical Neurosciences | February 22, 2019 | Volume: 31 | Issue: 3 | Pages: 196-200

10.1176/appi.neuropsych.18050118 | PMID 30791806

Anticholinergic Medications and Cognitive Function in Late Midlife

Alzheimer Disease & Associated Disorders | February 23, 2018 | Volume: 32 | Issue: 3 | Pages: 262-264

10.1097/wad.0000000000000251 | PMID 29481373